Sign In
Get Clay Free →

Suggestions

    Kevin Clark

    CEO at Now Diagnostics - NowDx

    Kevin Clark is a seasoned professional with a successful track record in the diagnostics industry. With a career spanning from founding a diagnostics company to selling it to a global life sciences giant, Kevin has extensive experience in managing multinational operations, leading as COO and CEO, overseeing mergers and acquisitions, and navigating the FDA approval process.

    His skills as a CEO of a multinational public company include managing revenues totaling $34 million as part of a larger $240 million group. Additionally, he has expertise in COO roles, mergers and acquisitions, FDA approval processes, diagnostic research and development, and raw materials manufacturing. Kevin has managed facilities across the U.S. in multiple states and internationally in various countries including England, the Czech Republic, Italy, Russia, Brazil, and France.

    In 1987, Kevin founded ImmunoVision, Inc., which he later sold to IVAX Corporation in 1995. The company was integrated into IVAX Diagnostics, Inc. Following a spin-off and merger in 2001, the company went public and traded on a national securities exchange. Over the years, Kevin transitioned to become COO and eventually CEO of the company, overseeing significant growth and successful acquisitions.

    Kevin's leadership led to selling the company's controlling interest to a French investment group and later brokering a deal with Erba Diagnostics Mannheim GmbH in 2010. During his tenure as CEO, the public company's revenue surged from $16 million to $34 million. Kevin now serves as the CEO at NOWDiagnostics, bringing his wealth of experiences and skills to drive innovation and growth in the diagnostics sector.

    K
    Add to my network

    Location

    Springdale, Arkansas